Abbott to distribute MSD's diabetes drug in India
Abbott and MSD Pharmaceuticals have entered into a distribution agreement for MSD's oral anti-diabetic medicine sitagliptin, its combination sitagliptin/metformin and the extended-release version in India.
Leveraging its broad footprint in the country Abbott will distribute the portfolio. The products are marketed under brand names Januvia, Janumet and Janumet XR, the companies said in a joint statement.
Sitagliptin is a Dipeptidyl Peptidase IV Inhibitors used for treatment of Type 2 diabetes. It was discovered and developed by MSD Pharmaceuticals and the first DPP4i to be launched in India in 2008. The brands under this portfolio continue to be among the leaders in the category, even after loss of exclusivity, they said.
'Through our extensive presence, we can help people in India better manage their Type 2 diabetes and take control of their health,' V-P of Abbott in India Ambati Venu said.
MSD India Region Managing Director Rehan A. Khan said, 'Our partnership with Abbott establishes a sustainable business model that will enable us to continue to serve patients throughout India with these diabetes treatments.'
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
India Today
5 hours ago
- India Today
Stocks to watch June 19: HDFC Bank, Jio Financial, Hero, Abott, Tata Elxsi
Stock markets ended slightly in the red on Tuesday, continuing a phase of consolidation. With the US Federal Reserve deciding to keep its key lending rate unchanged, traders and investors in India may react cautiously in today's session. On June 19, several companies will be in focus due to corporate actions, new developments, or earnings Aegis Logistics and Aegis Vopak Terminals will announce their quarterly results today. Investors will closely watch their performance, especially in light of global supply chain movements and energy BANK HDFC Bank may draw attention as its CEO Sashidhar Jagdishan has approached the Bombay High Court seeking to cancel an FIR filed against him by the Lilavati Trust. The matter is likely to stay in focus until further updates come MOTOCORPHero MotoCorp has announced the launch of its Vida VX2 electric scooters. The rollout will begin on July 1, 2025. The scooters will be offered with a Battery-as-a-Service model, which means customers can use the battery on a subscription basis rather than buying it outright. This move could improve the affordability and reach of electric vehicles in INDIAAbbott India has entered into a distribution agreement with MSD Pharmaceuticals. The partnership aims to widen access to MSD's oral anti-diabetes medicines in India. The agreement includes Sitagliptin-based products that are used to manage Type 2 diabetes. This deal is expected to strengthen Abbott's reach in the diabetes treatment ENERGYShares of Siemens Energy India will debut on the stock market today following its demerger from parent company Siemens. The listing comes after months of preparation, and investors will be watching how the shares perform on the first day of FINANCIAL SERVICESJio Financial Services acquired over 7.9 crore equity shares worth Rs 104.54 crore of Jio Payments Bank (JPBL) from the State Bank of India (SBI). This transaction took place after receiving approval from the Reserve Bank of India on June 4. The deal strengthens Jio Financial's position in the digital banking and payments SMALL FINANCE BANKESAF Small Finance Bank has approved the sale of a group of non-performing and technically written-off loans worth Rs 735.18 crore to an asset reconstruction company (ARC). The move is part of the bank's plan to clean up its balance sheet and reduce bad ELXSITata Elxsi has partnered with Infineon Technologies to co-develop application-ready electric vehicle (EV) solutions for the Indian market. The partnership will focus on designing systems that are tailored for local needs, helping manufacturers build efficient and affordable estate developer Puravankara has secured a new project in Bengaluru. The company bagged a contract worth Rs 272 crore for a residential development, which could support its revenue growth in upcoming LIFESCIENCESZydus Lifesciences is also in focus after the US Food and Drug Administration (US FDA) issued two observations following an inspection at the company's oncology injectable unit located at SEZ 1 near Matoda, Ahmedabad. Investors will be awaiting further clarity on the impact of these observations.
Mint
7 hours ago
- Mint
Stocks to watch: Jio Financial, Hero Motocorp, Vodafone Idea, Siemens among shares in focus today
The bank said it acquired 7,90,80,000 equity shares of Jio Payments Bank Limited (JPBL) from State Bank of India for ₹ 104.54 crore. A pharmaceutical company announced that a recent inspection by the U.S. Food and Drug Administration (FDA) at its oncology injectable facility in Ahmedabad ended with two observations, neither of which relate to data integrity. Indian two-wheeler maker has announced the launch of its Vida Vx2 electric scooter under a new 'Battery-as-a-Service' (BaaS) model. Abbott has entered into an agreement with MSD Pharmaceuticals to distribute Sitagliptin-based diabetes medications from MSD in India. ESAF Small Finance Bank has given the go-ahead to sell a portfolio of non-performing and technically written-off loans amounting to ₹ 735.18 crore to an asset reconstruction company (ARC). The telecom operator announced that it has entered into a strategic partnership with AST SpaceMobile Inc. to deliver direct-to-device satellite broadband connectivity in India, aligning with the Digital India initiative to ensure universal mobile access. The company announced that it has entered into a Memorandum of Understanding (MoU) with Infineon Technologies to collaboratively create EV solutions customized for the Indian market. The technology company announced that Siemens Energy India Limited (SEIL) has secured approvals from both the BSE and the National Stock Exchange of India for the listing and trading of its equity shares, which will take effect from June 19, 2025. HDFC Bank CEO Sashidhar Jagdishan has approached the Bombay High Court, requesting the dismissal of an FIR lodged against him by the Lilavati Trust. The company announced that its board's executive committee has given the green light to raise up to ₹ 200 crore via a private placement of non-convertible debentures (NCDs). Disclaimer: This story is for educational purposes only. The views and recommendations above are those of individual analysts or broking companies, not Mint. We advise investors to check with certified experts before making any investment decisions.
Time of India
8 hours ago
- Time of India
Stocks in news: Siemens Energy, Jio Financial, Hero MotoCorp, ESAF SFB, Abbott India
Markets traded lackluster and ended marginally in the red, extending the ongoing consolidation phase. In today's trade, shares of Siemens Energy , Jio Financial , Hero MotoCorp , ESAF SFB, Abbott India among others will be in focus due to various news developments. Siemens Energy Shares of Siemens Energy India will list on Thursday following the long-awaited demerger from parent Siemens. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like These Photos Captured the Exact Wrong Moment Read More Undo Jio Financial Jio Financial Services acquired over 7.9 crore equity shares worth Rs 104.54 crore of Jio Payments Bank (JPBL) from SBI following a Reserve Bank's nod on June 4. ESAF SFB ESAF Small Finance Bank has approved the sale of a pool of non-performing and technically written-off loans worth Rs 735.18 crore to an asset reconstruction company (ARC). Tata Elxsi Tata Elxsi partnered with Infineon to jointly develop application-ready EV solutions tailored for the Indian market. Live Events Abbott Abbott signed a agreement with MSD Pharmaceuticals to distribute MSD's Sitagliptin-based diabetes medicines in India. HDFC Bank HDFC Bank CEO Sashidhar Jagdishan moved Bombay High Court seeking quashing of FIR filed against him by Lilavati Trust. Zydus Lifesciences US FDA issued two observations for company's oncology injectable site situated at SEZ 1, near Matoda, Ahmedabad. Hero MotoCorp Hero MotoCorp to introduce VIDA VX2 with 'Battery-As-A-Service' model on July 1.
